DGX — Quest Diagnostics

Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Employees: 46,000 · Website: https://www.questdiagnostics.com · Profile fields populated: 75%

Data completeness by statement

Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/DGX/financials.

Financial statement coverage (USD)

Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

Get DGX data via the API

Every number on this page is one API call away. Free API keys — no card required.

Other NYSE · Health Care companies covered

Frequently Asked Questions

What data does the API provide for DGX?

Company profile, financial statements, computed ratios, price data, filings and news for DGX, via REST endpoints under /api/v1/companies/DGX. Every financial field carries a source tag for provenance.

How complete is DGX's financial data?

The anchor reporting period (FY2025) has 100.0% of the 17 core statement fields populated. Primary source: sec_edgar.

What reporting periods are covered for DGX?

5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/DGX/financials.

Where does DGX's data come from?

Primary source for the latest statements: sec_edgar. The API records a source tag on every field and exposes them via /api/v1/companies/DGX/financials, so each value is traceable.